Ultrasound technology startup Exo has garnered $220 million in a series C investment round.
The financing round was led by RA Capital Management, with participation by BlackRock, Sands Capital, Avidity Partners, Pure Vida Investments, and prior investors, according to Exo. The company said it would use the proceeds to fund the commercialization of its handheld ultrasound device and its Exo Works point-of-care ultrasound workflow software.
